Published in J Am Soc Nephrol on May 03, 2006
Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients (RAND) | NCT01195818
Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol (2010) 2.27
Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Acta Diabetol (2014) 1.48
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2009) 1.17
Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care (2010) 1.08
Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diabetes (2012) 1.06
Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes. J Diabetes Complications (2013) 0.98
Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes. Diabetes Care (2011) 0.93
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes. Diabetes Care (2012) 0.92
Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2012) 0.91
The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2010) 0.91
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study. Diabetes Care (2008) 0.91
Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise. Clin Sci (Lond) (2007) 0.88
Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes. Diabetes Care (2010) 0.85
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. PLoS One (2013) 0.83
Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes. Nephrol Dial Transplant (2015) 0.82
Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. World J Diabetes (2013) 0.82
Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese. PLoS One (2012) 0.81
The urinary cytokine/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes. PLoS One (2014) 0.78
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review. Adv Ther (2016) 0.77
The renal effects of SGLT2 inhibitors and a mini-review of the literature. Ther Adv Endocrinol Metab (2016) 0.75
Stop chronic kidney disease progression: Time is approaching. World J Nephrol (2016) 0.75
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol (2017) 0.75
Effects of glycaemic management on diabetic kidney disease. World J Diabetes (2017) 0.75
Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008-2011). Medicine (Baltimore) (2017) 0.75
Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies. Diabet Med (2017) 0.75
Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol (2007) 3.66
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol (2005) 2.25
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int (2008) 1.99
Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol (2006) 1.91
Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int (2002) 1.88
Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes (2009) 1.78
Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiol Renal Physiol (2014) 1.64
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int (2011) 1.63
Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int (2004) 1.62
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial. Diabetes Care (2014) 1.60
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer. J Thorac Oncol (2006) 1.57
Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis. J Mol Diagn (2011) 1.57
Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol (2007) 1.55
Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine. Kidney Int (2008) 1.50
Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension (2010) 1.45
Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res (2007) 1.40
Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol (2004) 1.36
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol (2006) 1.35
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail (2009) 1.29
The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes (2007) 1.24
Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension (2003) 1.23
Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant (2002) 1.22
Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation (2010) 1.18
Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. Diabetes (2002) 1.17
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2009) 1.17
The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant (2008) 1.14
Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol (2002) 1.11
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res (2008) 1.11
Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol (2009) 1.10
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09
Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol (2005) 1.08
Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care (2010) 1.08
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration. Diabetologia (2014) 1.05
Activation of mesangial cell MAPK in response to homocysteine. Kidney Int (2004) 1.04
A molecular signature of proteinuria in glomerulonephritis. PLoS One (2010) 1.03
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res (2011) 1.01
Using an electronic self-management tool to support patients with chronic kidney disease (CKD): a CKD clinic self-care model. Semin Dial (2013) 1.01
Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy postmenopausal women. Hypertension (2005) 0.97
The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens (2004) 0.97
Nitric oxide inhibits stretch-induced MAPK activation in mesangial cells through RhoA inactivation. J Am Soc Nephrol (2003) 0.94
Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy. Curr Opin Nephrol Hypertens (2015) 0.94
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes. Diabetes Care (2012) 0.92
Searching for new biomarkers of renal diseases through proteomics. Clin Chem (2011) 0.92
Necrotizing glomerulonephritis caused by Bartonella henselae endocarditis. Am J Kidney Dis (2004) 0.92
Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Can J Cardiol (2004) 0.92
Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int (2005) 0.92
Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2012) 0.91
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study. Diabetes Care (2008) 0.91
The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care (2010) 0.91
Insights into the regulation of renal hemodynamic function in diabetic mellitus. Curr Diabetes Rev (2008) 0.91
Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2010) 0.90
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol (2008) 0.90
Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. J Am Soc Nephrol (2004) 0.89
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus. Kidney Int (2013) 0.88
Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways. Am J Physiol Renal Physiol (2013) 0.88
Cystic adventitial pathology as an entity in peripheral arterial disease. J Cardiovasc Surg (Torino) (2015) 0.87
Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int (2003) 0.87
Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am J Physiol Renal Physiol (2011) 0.86
Loss of TIMP3 selectively exacerbates diabetic nephropathy. Am J Physiol Renal Physiol (2012) 0.86
Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes. Diabetes Care (2010) 0.85
The role of ACE2 in pulmonary diseases--relevance for the nephrologist. Nephrol Dial Transplant (2009) 0.84
Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol (2005) 0.84
17beta -Estradiol modulates mechanical strain-induced MAPK activation in mesangial cells. J Biol Chem (2002) 0.83
The angiotensin II receptor type 2 polymorphism influences haemodynamic function and circulating RAS mediators in normotensive humans. Nephrol Dial Transplant (2010) 0.83
The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics. BMC Pediatr (2014) 0.83
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. PLoS One (2013) 0.83
A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy. Am J Pathol (2004) 0.82
Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse. Diabetologia (2015) 0.81
Sex differences in renal responses to hyperglycemia, L-arginine, and L-NMMA in humans with uncomplicated type 1 diabetes. Diabetes Care (2012) 0.79
Impact of gender on renal disease: the role of the renin angiotensin system. Clin Invest Med (2003) 0.79
Markers of inflammation in recipients of continuous-flow left ventricular assist devices. ASAIO J (2014) 0.79
Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes. Diabetes (2003) 0.79
Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol (2012) 0.79
The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes. Diabetologia (2013) 0.78
New and old agents in the management of diabetic nephropathy. Curr Opin Nephrol Hypertens (2016) 0.78
Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes. Clin Exp Hypertens (2012) 0.78
Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC). J Biol Chem (2013) 0.78